tx000045
·Code: TX000045, TX45
tx000045: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Tectonic Therapeutic, Inc. (TECX) | Phase 2 |
Clinical Trials (1)
An Open-Label Study to Assess the Hemodynamic Effect and the Safety of TX000045 After 16 Weeks of Treatment in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
Frequently asked questions
Who is developing tx000045?
tx000045 is being developed by Tectonic Therapeutic, Inc..
How many clinical trials involve tx000045?
BioSniper tracks 1 clinical trial involving tx000045.
Get deeper analysis on tx000045
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis